Predictive Oncology Exchanges $2.1 Million of Debt for Equity, Streamlining Capital Structure and Simplifying Balance Sheet

NEXT STORY
Novartis announces data showing Jakavi® (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease
PREV STORY
Chiasma Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

author_avatar
NASDAQ Market News

Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn’s disease.

Amsterdam, The Netherlands -17th May 2018 Esperite's The Cell Factory has signed today the agreement with ...

author_avatar
NASDAQ Market News

Merus kündigt die Annahme von sechs Abstracts bei bevorstehenden medizinischen Konferenzen an und bietet Programm-Updates

author_avatar
NASDAQ Market News